PRELIMINARY FINDINGS FROM THE PHASE 2 EPPIK STUDY OF SPARSENTAN IN PEDIATRIC PATIENTS WITH SELECTED PROTEINURIC GLOMERULAR DISEASES

14 Apr 2024 5:45 p.m. 6:45 p.m.
WCN24-AB-774, Poster Board= SUN-048
Radko Komers Poster Presenter